drugset / Trial / NCT00601861
Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The trial is conducted in Europe. This trial aims for a comparison of the pathology in lymph nodes before and after the effect of recombinant interleukin-21 in patients with stage III melanoma
Timeline
- Start
- 2008-02-13
- Primary completion
- 2008-06-25
- Completion
- 2008-06-25
Outcome
Outcome not reported
Stopped: “See termination reason in detailed description”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant interleukin-21 | Protein / enzyme biologic | — | Subcutaneous |